Atlas Trials

Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT01170052 · WITHDRAWN

Trial details

NCT number
NCT01170052
Sponsor
Charite University, Berlin, Germany
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mantle Cell Lymphoma
Start date
2010-05-01
Primary completion
2012-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.